Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review
- PMID: 28345830
- PMCID: PMC5454743
- DOI: 10.22034/APJCP.2017.18.2.459
Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review
Abstract
Background: Urothelial carcinoma (UC) is the malignancy most frequently encountered in the urinary bladder.The primary aim of this study was to make a reappraisal of histopathologic features, recurrence and progression. Materials and Methods: The records of cases consecutively diagnosed with UC in the state hospital pathology laboratory were collected. Cases were classified according to age, gender, histologic grade, pathologic staging [primary Tumor (pT)] ,tumor configuration, primary or recurrent status, and progression. Results: A total of 35 (29 male and 6 female) cases were examined. The mean age was 68.9 years with a male-to-female incidence ratio of 4.8:1. Low-grade UCs accounted for 20 (57.1%) and high-grade for 15 (42.9%). A papillary pattern was observed in 80% of the UCs, classified into the following pathological stages: 11 (31.4%) pTa, 22 (62.9%) pT1, and 2 (5.9%) pT2 cases. Eleven patients progressed to a higher stage (pT1 to pT2), and three cases from low to higher grade. We analyzed results for 26 (74.3%) cases aged 65 years or older. Conclusions: UCs have a great tendency for recurrence but potentially may be amenable to effective local or systemic treatments.
Keywords: Bladder; carcinoma; grade; stage; progression; recurrence; urothelial.
Creative Commons Attribution License
Figures
Similar articles
-
Histopathological evaluation of urothelial carcinomas in transurethral resection urinary bladder tumor specimens: eight years of single center experience.Asian Pac J Cancer Prev. 2015;16(7):2871-7. doi: 10.7314/apjcp.2015.16.7.2871. Asian Pac J Cancer Prev. 2015. PMID: 25854375
-
Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.Indian J Pathol Microbiol. 2013 Jan-Mar;56(1):10-5. doi: 10.4103/0377-4929.116141. Indian J Pathol Microbiol. 2013. PMID: 23924551
-
PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.Cancer. 2007 Apr 15;109(8):1499-505. doi: 10.1002/cncr.22588. Cancer. 2007. PMID: 17340590
-
CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.J Coll Physicians Surg Pak. 2014 May;24(5):351-5. J Coll Physicians Surg Pak. 2014. PMID: 24848395
-
Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.Adv Anat Pathol. 2011 Jan;18(1):79-89. doi: 10.1097/PAP.0b013e318204c0cf. Adv Anat Pathol. 2011. PMID: 21169741 Review.
Cited by
-
Correlation of HER2 With p53 and p63 in Urothelial Bladder Carcinoma.Cureus. 2023 Apr 23;15(4):e38018. doi: 10.7759/cureus.38018. eCollection 2023 Apr. Cureus. 2023. PMID: 37228532 Free PMC article.
References
-
- Akagashi K, Tanda H, Kato S, et al. Recurrence pattern for superficial bladder cancer. Int J Urol. 2006;13:686–91. - PubMed
-
- Alsheikh A, Mohamedali Z, Jones E, et al. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors, World/health organization/internattional society of urologic pathology. Mod Pathol. 2001;14:267–72. - PubMed
-
- Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234–41. - PubMed